Caplin Point Laboratories informs about financial results

07 May 2025 Evaluate
Caplin Point Laboratories has informed that a meeting of the Board of Directors of the Company will be held on Thursday, May 15, 2025, to consider and approve the annual audited financial results of the Company for the year ended March 31, 2025 (both standalone & consolidated) and declaration of Interim Dividend, if any, for the FY 2024-25 and fixation of record date for determining the eligibility of shareholders. This intimation is being given in compliance with the provisions of Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. As informed earlier vide letter dated March 25, 2025, the trading window for dealing in the Company’s scrips by the Designated Persons commenced on April 1, 2025 and will remain closed till May 17, 2025, in terms of the Company’s Code of Conduct to regulate, monitor and report trading by insiders, read with SEBI (Prohibition of Insider Trading) Regulations, 2015. 

The above information is a part of company’s filings submitted to BSE.

Caplin Point Lab Share Price

1741.25 -35.50 (-2.00%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×